Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods-Reference-Cited by-同舟云学术

Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods

Published:2020-12-01 Issue:6 Volume:3 Page:440-453
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

Chaudhari Hemangi G.¹,Penterman Jon¹,Whitton Holly J.²,Spencer Sarah J.¹,Flanagan Nicole¹,Lei Zhang Maria C.¹,Huang Elaine¹,Khedkar Aditya S.¹,Toomey J. Mike¹,Shearer Courtney A.¹,Needham Alexander W.¹,Ho Tony W.¹,Kulman John D.¹,Cradick T.J.³,Kernytsky Andrew¹

Affiliation:

1. CRISPR Therapeutics, Inc., Cambridge, Massachusetts, USA; San Francisco, California 94102, USA.

2. TScan Therapeutics, Waltham, Massachusetts, USA; and San Francisco, California 94102, USA.

3. Excision BioTherapeutics, San Francisco, California 94102, USA.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/crispr.2020.0053

Reference33 articles.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large Serine Integrase Off-target Discovery and Validation for Therapeutic Genome Editing;2024-08-24

2. Building CRISPR Gene Therapies for the Central Nervous System;JAMA Neurology;2024-03-01

3. Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity;Molecular Therapy - Methods & Clinical Development;2023-12

4. Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy;Journal of Experimental Medicine;2023-09-29

5. Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates;Gene Therapy;2023-08-17